ArticleRevista brasileira de enfermagem2026
Use of COVID-19 Detection Tests in the Mexican Population from 2020-2022: Frequency and Distribution.
Article in Revista brasileira de enfermagem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAnalyze the frequency and distribution of COVID-19 diagnostic testing (RT-PCR and Ag-RDT) in Mexico during 2020-2022, and identify the sociodemographic and regional factors associated with their use.
methodsEcological and cross-sectional study using secondary data from the National Epidemiological Surveillance System for Respiratory Diseases (SISVER). Approximately 15 million tests performed in public and private institutions between June 2020 and April 2022 were analyzed at individual and municipal levels to describe distribution by sex, age, social security coverage, and regional marginalization.
resultsAg-RDT was the most frequently used test nationwide, with testing concentrated in Mexico City and other economically developed regions, while marginalized and predominantly indigenous areas showed the lowest testing rates.
conclusionSignificant inequalities were found in access to COVID-19 testing in Mexico, highlighting the influence of socioeconomic and territorial disparities and the need for equity-oriented public health and nursing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.